ABT Stock Chart & Fundamental Analysis

Interactive Chart

About Abbott Laboratories

Name

Abbott Laboratories

CEO

Robert Ford

Website

www.abbott.com

Industry

Healthcare

Year Founded

1888

Employees

114,000

Abbott Laboratories (NYSE: ABT) is a healthcare company centered on medical devices, diagnostics, nutrition, and branded generic medications sold through worldwide distribution, with operations that reach global markets. Across these businesses, Abbott generated $44.3 billion of revenue in FY2025, spanning products used in testing, chronic disease management, and everyday nutritional care.

Analyst Ratings

Consensus Recommendation

Buy4

Hold2

Sell1

Fundamentals & Financials

Revenue (TTM)

$45.1B

Net Income (TTM)

$6.2B

EPS (TTM)

$3.6

ROA (TTM)

5.68%

Current Ratio

1.39

Dividend Yield

0.61%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q1 FY2026	Q4 FY2025	Q3 FY2025
Revenue	$11,164M	$11,459M	$11,369M
Cost of Sales	$4,881M	$4,922M	$5,031M
Gross Profit	$6,283M	$6,537M	$6,338M
Operating Income	$1,842M	$2,251M	$2,057M
Net Income	$1,077M	$1,776M	$1,644M
EPS	$0.62	$1.02	$0.94

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

Abbott Laboratories's Technical Indicators Summary

ABT carries a bullish bias with price above its short- and medium-term moving averages and positive readings from CCI and MACD, while RSI shows constructive momentum. Trend strength is moderate with ADX in the low 20s and volatility remains contained, and the classic pivot lies below the current level providing nearby support. Longer-term averages are higher and temper the outlook somewhat, and on-balance volume signals accumulation despite that divergence. Technical takeaway: Buy—short- and medium-term momentum and volume support the positive bias.

Buy

4 signals

Neutral

2 signals

Sell

1 signal

Overall: Bullish57% Bullish signals

Indicator	Value	Signal	Explanation
RSI (14)	62.71	Neutral	RSI (62.71) is neutral.
Stochastic %K (14, 3, 3)	67.98	Neutral	Stochastic (67.98) is neutral.
CCI (20)	151.87	Buy	CCI (151.87) > 100, indicating strong upward momentum.
WPR (14)	-3.92	Sell	Williams %R (-3.92) > -20, indicating overbought.
Momentum (10)	6.90	Buy	Momentum (6.90) is positive.
MFI	52.16	Neutral	MFI (52.16) is neutral.
MACD Level (12, 26)	1.07	Buy	Confirmed uptrend: MACD (1.07) is positive and above its signal line (0.54).
Bollinger Bands	$86.62 - $94.79	Sell	Price ($95.40) is above the upper band ($94.79).
ATR (14)	$2.52 (2.64%)	Neutral	Moderate Volatility (2.64%).
ADX (14)	21.01	Neutral	Weak or consolidating trend (ADX < 25). ADX(21.01), +DI(27.89), -DI(16.36)
OBV	-348,708,772	Buy	Bullish volume pressure: OBV is above its 20-day SMA. OBV(-348,708,772), 20D-SMA-OBV(-351,625,339)
Classic Pivot Point	$92.65	Buy	Price ($95.40) has broken above resistance R1 ($93.53) — bullish breakout potential.
Fibonacci Pivot Point	$92.65	Buy	Price ($95.40) has broken above resistance R1 ($93.50) — bullish breakout potential.
Simple Moving Averages	$88.93 - $111.83(5 indicators)	Buy	SMA group: 3/5 bullish, 2 bearish, 0 neutral. Price above key SMA averages.
Exponential Moving Averages	$90.89 - $109.02(5 indicators)	Buy	EMA group: 3/5 bullish, 2 bearish, 0 neutral. Price above key EMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

Closing levels show ABT still elevated versus yesterday, after a 3.49% gap. The day wrapped with modest participation in ABT, as overall volume reached only 0.57× average. ABT climbs on Dividend Kings dividend-growth narrative, highlighting its reliable income stream.

Trading Volume

vs S&P 500 Today

Strong Outperformance

+3.55%

52-Week Position

Lower range

24.2%

Updated: July 2, 2026 at 20:13 UTC